Literature DB >> 25781393

The effect of bifenthrin on the dopaminergic pathway in juvenile rainbow trout (Oncorhynchus mykiss).

Jordan Crago1, Daniel Schlenk2.   

Abstract

Bifenthrin is a type I pyrethroid pesticide, which has been shown to increase plasma estrogen concentrations in several fish models. The mechanism of action by which bifenthrin alters 17β-estradiol (E2) is unclear. E2 biosynthesis is regulated through pituitary follicle stimulating hormone, which is directly controlled by hypothalamic gonadotropin releasing hormone (GnRH2). Since dopaminergic signaling significantly influences GnRH2 release in fish, the goal of the study was to determine the effect of a 96 h and 2 weeks exposure to bifenthrin on dopaminergic signaling in juvenile rainbow trout (Oncorhynchus mykiss) (RT). Our results indicated that a decrease in dopamine receptor 2A (DR2A) expression was associated with a trend toward an increase in plasma E2 following exposure at 96 h and 2 weeks, and a significant increase in the relative expression of vitellogenin mRNA at 2 weeks. DR2A mRNA expression decreased 426-fold at 96 h and 269-fold at 2 weeks in the brains of 1.5 ppb (3.55 pM) bifenthrin treated RT. There was an increase in tyrosine hydroxylase transcript levels at 96 h, which is indicative of dopamine production in the brains of the 1.5 ppb (3.55 pM) bifenthrin treated RT. A significant increase in the relative expression of GnRH2 was observed at 96 h but a significant decrease was noted after 2 weeks exposure indicating potential feedback loop activation. These results indicate that the estrogenic-effects of bifenthrin may result in part from changes in signaling within the dopaminergic pathway, but that other feedback pathways may also be involved.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  -estradiol (E2); 17β; Bifenthin; Dopamine; Gonadotropin releasing hormone

Mesh:

Substances:

Year:  2015        PMID: 25781393     DOI: 10.1016/j.aquatox.2015.03.005

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  6 in total

1.  Chronic and acute risk assessment of human exposed to novaluron-bifenthrin mixture in cabbage.

Authors:  Kaiwei Shi; Li Li; Wei Li; Longfei Yuan; Fengmao Liu
Journal:  Environ Monit Assess       Date:  2016-08-22       Impact factor: 2.513

2.  Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio).

Authors:  Daniel F Frank; Galen W Miller; Danielle J Harvey; Susanne M Brander; Juergen Geist; Richard E Connon; Pamela J Lein
Journal:  Aquat Toxicol       Date:  2018-04-18       Impact factor: 4.964

3.  Evaluation of the estrogen receptor alpha as a possible target of bifenthrin effects in the estrogenic and dopaminergic signaling pathways in zebrafish embryos.

Authors:  Luísa Becker Bertotto; Subham Dasgupta; Sara Vliet; Stacia Dudley; Jay Gan; David C Volz; Daniel Schlenk
Journal:  Sci Total Environ       Date:  2018-10-09       Impact factor: 7.963

4.  Dietary Exposure to Bifenthrin and Fipronil Impacts Swimming Performance in Juvenile Chinook Salmon (Oncorhynchus tshawytscha).

Authors:  Jason T Magnuson; Neil Fuller; Kara E Huff Hartz; Sara Anzalone; Gregory W Whitledge; Shawn Acuña; Michael J Lydy; Daniel Schlenk
Journal:  Environ Sci Technol       Date:  2022-03-30       Impact factor: 11.357

5.  The Use of Non-targeted Lipidomics and Histopathology to Characterize the Neurotoxicity of Bifenthrin to Juvenile Rainbow Trout (Oncorhynchus mykiss).

Authors:  Jason T Magnuson; Leslie Caceres; Nathan Sy; Chenyang Ji; Philip Tanabe; Jay Gan; Michael J Lydy; Daniel Schlenk
Journal:  Environ Sci Technol       Date:  2022-07-25       Impact factor: 11.357

6.  Transcriptomic and Histopathological Effects of Bifenthrin to the Brain of Juvenile Rainbow Trout (Oncorhynchus mykiss).

Authors:  Jason T Magnuson; Kara E Huff Hartz; Corie A Fulton; Michael J Lydy; Daniel Schlenk
Journal:  Toxics       Date:  2021-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.